Influenza Vaccines – Challenges in Mammalian Cell Culture Technology

  • Yvonne Genzel
  • Josef Schulze-Horsel
  • Lars Möhler
  • Yury Sidorenko
  • Udo Reichl

Abstract

Experimental data as well as simulation results obtained by mathematical models for an influenza vaccine process with adherent MDCK cells clearly show that total cell number, specific virus replication rate and cell death due to virus infection (apoptosis) are the main factors to be taken into account for achieving high virus yields. In contrast, supply of cellular precursors and ATP for the synthesis of viral genome and virus specific proteins as well as multiplicity of infection seems not to limit virion formation.

Keywords

Cholesterol Carbohydrate Lactate Titration Influenza 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Genzel, Y., Behrendt, I., König, S., Sann, H., Reichl, U.; 2004, Vaccine, 22 (17–18): 2202–2208.CrossRefGoogle Scholar
  2. [2]
    Mahy, B.W.J., Kangro, H.O.; 1996. Virology methods manual. London: Academic press.Google Scholar
  3. [3]
    Möhler, L., Flockerzi, D., Sann, H., Reichl, U.; 2005, Biotechnol. Bioeng., 90 (1), 46–58.CrossRefGoogle Scholar
  4. [4]
    Sidorenko, Y. and Reichl, U., 2004, Biotechnol. Bioeng., 88 (1), 1–14.CrossRefGoogle Scholar
  5. [5]
    Ludwig, S., Planz, O., Pleschka, S., Wolff, T.; 2003, Trends Mol. Med., 9(2), 46–52.CrossRefGoogle Scholar

Copyright information

© Springer 2007

Authors and Affiliations

  • Yvonne Genzel
    • 1
  • Josef Schulze-Horsel
    • 1
  • Lars Möhler
    • 2
  • Yury Sidorenko
    • 2
  • Udo Reichl
    • 1
    • 2
  1. 1.Max Planck Institute for Dynamics of Complex Technical SystemsMagdeburgGermany
  2. 2.Lehrstuhl für BioprozesstechnikOtto-von-Guericke-Universität MagdeburgMagdeburgGermany

Personalised recommendations